(Q40622805)

22 September 2017

1 reference

title

What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease (English)

1 reference

22 September 2017

Dawkins HJ

1

1 reference

22 September 2017

Robbins PD

2

1 reference

22 September 2017

Smith KL

3

1 reference

22 September 2017

Sarna M

4

1 reference

22 September 2017

Harvey JM

5

1 reference

22 September 2017

Sterrett GF

6

1 reference

22 September 2017

Papadimitriou JM

7

1 reference

22 September 2017

publication date

1 December 1993

1 reference

Pathology, Research and Practice

22 September 2017

published in

1 reference

22 September 2017

volume

189

1 reference

22 September 2017

issue

10

1 reference

22 September 2017

page(s)

1233-1252

1 reference

Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

The molecular genetics of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Molecular themes in oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Structure and expression of oncogenes in surgical specimens of human breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Comparison and optimization of in situ hybridization procedures yielding rapid, sensitive mRNA detections

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Cellular and molecular aspects of neoplastic progression in the mammary gland

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Quantitation of oncogene products by computer-assisted image analysis and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

c-erbB-2 amplification and overexpression in breast cancer: evaluation and comparison of Southern blot, slot blot, ELISA and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

The neu-oncogene protein as a predictive factor for haematogenous metastases in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Expression of c-erbB2, TGF-beta 1 and pS2 genes in primary human breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Long-term survival in breast cancer related to overexpression of the c-erbB-2 oncoprotein: an immunohistochemical study using monoclonal antibody NCL-CB11.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Gene Amplification and Expression of the <i>neu </i>(c-erbB-2) Sequence in Human Mammary Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Formation and detection of RNA-DNA hybrid molecules in cytological preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Expression of the c-erbB-2 proto-oncogene protein in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

c-erbB-2 expression in benign and malignant breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

The c-erb B-2 proto-oncogene in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Overexpression of the c-erbB-2 protein in human breast tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

RNA-DNA Hybrids at the Cytological Level

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Amplification of a novel v-erbB-related gene in a human mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

The role of gene dosage and genetic transpositions in carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Evolution of tumours and the impact of molecular oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

HER-2 oncogene amplification and overall survival of breast carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Duct carcinoma in situ. Pathology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

An immunohistochemical study of the presence of c-erbB-2 protein in Paget's disease of the nipple

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Optimization of non-radioactive in situ hybridization: image analysis of varying pretreatment, hybridization and probe labelling conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

The value of assessing cell proliferation in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Tumor suppressor genes: a new era for molecular genetic studies of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Neu (c-erbB-2), a tumor marker in carcinoma of the female breast

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinomas of the female breast

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Human breast cancer: identification of populations with a high risk of early relapse in relation to both oestrogen receptor status and c-erbB-2 overexpression

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

c-erbB-2 oncoprotein expression in primary human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Expression of Her-2/neu oncogene protein product and epidermal growth factor receptors in surgical specimens of human breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Strategies for the analysis of oncogene overexpression. Studies of the neu oncogene in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Oncoprotein stability after tumour resection

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Prognosis and breast cancer. Recognition of lethal and favorable prognostic types

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Clinical significance of erbB-2 (HER-2/neu) protein

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

The pathology of breast cancer detected by mass population screening

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

c-erbB-2 oncogene as a prognostic marker in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

C-ERBB-2 oncogens protein inIn situ and invasive lobular breast neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Oncogene amplification and expression. Importance of methodologic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma--a detailed morphological analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

c-erbB-2 protein expression in node negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0). Assessment of 644 patients with median follow-up of 18 years

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Tumor suppressor genes: the puzzle and the promise

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Proto-oncogene amplification and homogeneously staining regions in human breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Gene amplification in cultured animal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Extrachromosomal DNA in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

The significance of oncogene amplification in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Cell kinetics as a prognostic marker in node-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

c-erbB-2 expression in different histological types of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Detection of specific sequences among DNA fragments separated by gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Neu receptor dimerization

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast carcinoma. A retrospective analysis of 176 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

c-erbB-2 and c-erbA-1 (ear-1) gene amplification and c-erbB-2 protein expression in Japanese breast cancers: their relationship to the histology and other disease parameters.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Genetic alterations during colorectal-tumor development

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

A point mutation in the neu oncogene mimics ligand induction of receptor aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Differential expression of cellular oncogenes in benign and malignant human breast tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Biochemical analysis of the ligand for the neu oncogenic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Growth factor receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Low metastatic potential of clone from murine colon adenocarcinoma 26 increased by transfection of activated c-erbB-2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

Expression of genes coding for pS2, c-erbB2, estrogen receptor and the H23 breast tumor-associated antigen. A comparative analysis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980853-8

7 January 2021

10.1016/S0344-0338(11)80853-8

Identifiers

DOI

0 references

1 reference